Arcturus Therapeutics
Global late-stage clinical messenger RNA medicines company. Learn more
Launch date
Employees
Market cap
$538m
Enterprise valuation
$309m (Public information from Sep 2024)
Share price
$21.02 ARCT
San Diego California (HQ)
Authorizing premium user...